Appendicitis while on alectinib for non-small cell lung cancer: a tale of two case reports
While appendicitis has not been previously described as an adverse effect of alectinib, its incidence in two patients at our center within several months following the administration of alectinib raises its suspicion as a possible adverse effect.
Authors
- Paul Wheatley‐Price (ORCID: https://orcid.org/0000-0002-3725-9767)
- Hely Shah (ORCID: https://orcid.org/0000-0003-4812-4742)
- Boaz Wong (ORCID: https://orcid.org/0000-0001-9407-4315)
- Harman Sekhon
- Sara Moore
Institutions
- University of Ottawa (CA)
- Ottawa Hospital (CA)
- Canadian Electricity Association (CA)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-26
- DOI
- https://doi.org/10.3389/fonc.2024.1398414
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.42